Boc-D-prolinol

We are Boc-D-prolinol CAS:83435-58-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Boc-D-prolinol
CAS.NO:83435-58-9
Molecular Formula:C10H19NO3
Molecular Weight:201.263

Synonyms:
1-Pyrrolidinecarboxylic acid, 2-(hydroxymethyl)-, 1,1-dimethylethyl ester, (2R)-
1-Boc-D-Prolinol
boc-d-pro-ol
(R)-(+)-1-Boc-2-pyrrolidinemethanol
(R)-tert-butyl 2-(hydroxymethyl)pyrrolidine-1-carboxylate
Boc-D-prolinol
N-Boc-D-prolinol
N-tert-Butoxycarbonyl-D-prolinol
N-(tert-Butoxycarbonyl)-D-prolinol
(+)-n-tboc-d-prolinol
(R)-1-Boc-2-pyrrolidinemethanol
tert-Butyl (2R)-2-(hydroxymethyl)pyrrolidine-1-carboxylate
(R)-1-Boc-2-(hydroxymethyl)pyrrolidine
(R)-1-(Tert-Butoxycarbonyl)-2-Pyrrolidinemethanol
N-t-BOC-D-Prolinol
2-Methyl-2-propanyl (2R)-2-(hydroxymethyl)-1-pyrrolidinecarboxylate

Physical and Chemical Properties:
Density:1.1±0.1 g/cm3
Boiling point: 289.5±13.0 °C at 760 mmHg
Melting point:59-62 ºC
Flash point: 128.9±19.8 °C
Refractive index: 1.484

Specification:
Appearance:White Powder
Purity:≥99%
Loss on drying:≤0.2% 
Residue on ignition:≤0.1%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at 0ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.

Related News: More serious cases could lead to potentially deadly conditions such as pneumonia and kidney failure, with the former having been reported among some patients in China.Oxirane CAS:75-21-8 The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said.4,5-Dimethyl-2-isobutyl-3-thiazoline CAS:65894-83-9 The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.Ácido 4-bromo-2-nitrobenzoico CAS:99277-71-1 The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs.